Molecular portraits of human breast tumours - PubMed (original) (raw)
. 2000 Aug 17;406(6797):747-52.
doi: 10.1038/35021093.
T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen, O Fluge, A Pergamenschikov, C Williams, S X Zhu, P E Lønning, A L Børresen-Dale, P O Brown, D Botstein
Affiliations
- PMID: 10963602
- DOI: 10.1038/35021093
Molecular portraits of human breast tumours
C M Perou et al. Nature. 2000.
Abstract
Human breast tumours are diverse in their natural history and in their responsiveness to treatments. Variation in transcriptional programs accounts for much of the biological diversity of human cells and tumours. In each cell, signal transduction and regulatory systems transduce information from the cell's identity to its environmental status, thereby controlling the level of expression of every gene in the genome. Here we have characterized variation in gene expression patterns in a set of 65 surgical specimens of human breast tumours from 42 different individuals, using complementary DNA microarrays representing 8,102 human genes. These patterns provided a distinctive molecular portrait of each tumour. Twenty of the tumours were sampled twice, before and after a 16-week course of doxorubicin chemotherapy, and two tumours were paired with a lymph node metastasis from the same patient. Gene expression patterns in two tumour samples from the same individual were almost always more similar to each other than either was to any other sample. Sets of co-expressed genes were identified for which variation in messenger RNA levels could be related to specific features of physiological variation. The tumours could be classified into subtypes distinguished by pervasive differences in their gene expression patterns.
Similar articles
- Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN, Smith RA, Tiang T, Weinstein SR, Haupt LM, Griffiths LR. Gabrovska PN, et al. Gene. 2011 Dec 10;489(2):63-9. doi: 10.1016/j.gene.2011.08.024. Epub 2011 Sep 2. Gene. 2011. PMID: 21925246 - Microarrays in primary breast cancer--lessons from chemotherapy studies.
Lønning PE, Sørlie T, Perou CM, Brown PO, Botstein D, Børresen-Dale AL. Lønning PE, et al. Endocr Relat Cancer. 2001 Sep;8(3):259-63. doi: 10.1677/erc.0.0080259. Endocr Relat Cancer. 2001. PMID: 11566617 - Systematic variation in gene expression patterns in human cancer cell lines.
Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D, Brown PO. Ross DT, et al. Nat Genet. 2000 Mar;24(3):227-35. doi: 10.1038/73432. Nat Genet. 2000. PMID: 10700174 - Molecular profiling of breast cancer: portraits but not physiognomy.
Brenton JD, Aparicio SA, Caldas C. Brenton JD, et al. Breast Cancer Res. 2001;3(2):77-80. doi: 10.1186/bcr274. Epub 2000 Dec 18. Breast Cancer Res. 2001. PMID: 11250749 Free PMC article. Review. - Molecular portraits of breast cancer: tumour subtypes as distinct disease entities.
Sørlie T. Sørlie T. Eur J Cancer. 2004 Dec;40(18):2667-75. doi: 10.1016/j.ejca.2004.08.021. Eur J Cancer. 2004. PMID: 15571950 Review.
Cited by
- Proteogenomic analysis dissects early-onset breast cancer patients with prognostic relevance.
Yoon KA, Kim Y, Jung SY, Ryu JS, Kim KH, Lee EG, Chae H, Kwon Y, Kim J, Park JB, Kong SY. Yoon KA, et al. Exp Mol Med. 2024 Nov;56(11):2382-2394. doi: 10.1038/s12276-024-01332-w. Epub 2024 Nov 1. Exp Mol Med. 2024. PMID: 39482530 Free PMC article. - The wonders of X-PDT: an advance route to cancer theranostics.
Mushtaq A, Iqbal MZ, Tang J, Sun W. Mushtaq A, et al. J Nanobiotechnology. 2024 Oct 25;22(1):655. doi: 10.1186/s12951-024-02931-5. J Nanobiotechnology. 2024. PMID: 39456085 Free PMC article. Review. - Undercutting efforts of precision medicine: roadblocks to minority representation in breast cancer clinical trials.
Saini G, Gogineni K, Kittles RA, Aneja R. Saini G, et al. Breast Cancer Res Treat. 2021 Jun;187(3):605-611. doi: 10.1007/s10549-021-06264-x. Epub 2021 Jun 2. Breast Cancer Res Treat. 2021. PMID: 34080093 Review. - FBXO15 plays a critical suppressive functional role in regulation of breast cancer progression.
Zhao Y, Shim N, Cui YH, Kang JH, Yoo KC, Kim S, Yi JM, Kim MJ, Yoon JH, Lee SJ. Zhao Y, et al. Signal Transduct Target Ther. 2021 Jun 4;6(1):211. doi: 10.1038/s41392-021-00605-4. Signal Transduct Target Ther. 2021. PMID: 34083507 Free PMC article. No abstract available. - Molecular characterization of basal-like and non-basal-like triple-negative breast cancer.
Prat A, Adamo B, Cheang MC, Anders CK, Carey LA, Perou CM. Prat A, et al. Oncologist. 2013;18(2):123-33. doi: 10.1634/theoncologist.2012-0397. Epub 2013 Feb 12. Oncologist. 2013. PMID: 23404817 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical